88. Chronic thromboembolic pulmonary hypertension
145 clinical trials,   112 drugs   (DrugBank: 22 drugs),   13 drug target genes,   52 drug target pathways

Searched query = "Chronic thromboembolic pulmonary hypertension", "CTEPH", "Idiopathic chronic pulmonary thromboembolism"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT01953965
(ClinicalTrials.gov)
September 201326/9/2013Look at Way the Heart Functions in People With Pulmonary Hypertension (PH) Who Have Near Normal Right Ventricle (RV) Function and People With Pulmonary Hypertension Who Have Impaired RV Function. Using Imaging Studies PET Scan and Cardiac MRI.11C-acetate/18Fluorodeoxyglucose-FDG PET/Cardiac MRI in Pulmonary HypertensionPulmonary Arterial Hypertension;Chronic Thromboembolic Pulmonary HypertensionDrug: 11C-acetate;Drug: [18F]Fluoro-2-deoxy-2-D-glucose;Drug: MultiHanceBrigham and Women's HospitalUniversity of Pennsylvania;University of Maryland;Yale UniversityTerminated18 Years72 YearsBoth4Phase 2United States